Bioventix PLC (AIM:BVXP)
London · Delayed Price · Currency is GBP · Price in GBX 1,785.00
+35.00 (2.00%)
Oct 15, 2026, 4:10 PM GMT
Bioventix Market Cap
Bioventix has a market cap or net worth of 91.44 million as of October 15, 2026. It is the 23,998th most valuable company in the world and the 522nd biggest in the United Kingdom. Its market cap has decreased by 26.32% in one year.
Market Cap
91.44M
Enterprise Value
86.13M
Revenue
12.54M
Global Rank
Country Rank
#522 United Kingdom
PE Ratio
12.45
ChartMarket Cap Chart
Since April 8, 2010, Bioventix's market cap has increased from 9.85M to 91.44M, an increase of 828.51%. That is a compound annual growth rate of 14.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 91.44M | -8.14% |
| Dec 31, 2025 | 99.53M | -39.94% |
| Dec 31, 2024 | 165.72M | -26.16% |
| Dec 29, 2023 | 224.45M | 7.98% |
| Dec 30, 2022 | 207.85M | 17.35% |
| Dec 31, 2021 | 177.12M | -22.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Avacta Group | 309.11M |
| PureTech Health | 274.11M |
| Scancell Holdings | 113.34M |
| 4basebio | 87.40M |
| Faron Pharmaceuticals Oy | 72.43M |
| Hemogenyx Pharmaceuticals | 52.36M |
| Ondine Biomedical | 50.66M |
| Poolbeg Pharma | 49.62M |